Caris Life Sciences, Inc.
CAI
$18.26
-$0.21-1.14%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 798.57M | 755.49M | 721.18M | 33.43M | 66.15M |
| Total Receivables | 112.14M | 26.70M | 50.89M | 80.17M | 88.24M |
| Inventory | 63.63M | 49.30M | 40.61M | 36.55M | 39.57M |
| Prepaid Expenses | 19.59M | 18.66M | 16.58M | 11.92M | 13.56M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 3.88M | 4.10M | 4.06M | 9.16M | 8.20M |
| Total Current Assets | 997.80M | 854.25M | 833.32M | 171.23M | 215.73M |
|
|
|||||
| Total Current Assets | 997.80M | 854.25M | 833.32M | 171.23M | 215.73M |
| Net Property, Plant & Equipment | 103.02M | 64.00M | 61.32M | 61.65M | 102.77M |
| Long-term Investments | 19.34M | 19.34M | 19.34M | 19.34M | 19.34M |
| Goodwill | 19.34M | 19.34M | 19.34M | 19.34M | 19.34M |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 5.50M | 46.99M | 41.08M | 39.36M | 5.89M |
| Total Assets | 1.13B | 984.57M | 955.06M | 291.58M | 343.73M |
|
|
|||||
| Total Accounts Payable | 39.21M | 29.00M | 28.73M | 24.23M | 27.79M |
| Total Accrued Expenses | 56.92M | 47.63M | 48.73M | 64.55M | 63.99M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6.53M | 6.61M | 7.39M | 66.12M | 66.17M |
| Total Finance Division Other Current Liabilities | 24.49M | 2.79M | 5.34M | 7.66M | 7.47M |
| Total Other Current Liabilities | 24.49M | 2.79M | 5.34M | 7.66M | 7.47M |
| Total Current Liabilities | 127.15M | 86.03M | 90.18M | 162.55M | 165.42M |
|
|
|||||
| Total Current Liabilities | 127.15M | 86.03M | 90.18M | 162.55M | 165.42M |
| Long-Term Debt | 378.45M | 376.30M | 373.61M | 316.64M | 319.20M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 42.71M | 43.83M | 37.98M | 37.07M | 38.89M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 53.00K | 53.00K | 380.00K | 129.07M | 97.41M |
| Total Liabilities | 548.36M | 506.21M | 502.15M | 645.34M | 620.92M |
|
|
|||||
| Common Stock & APIC | 3.14B | 3.13B | 3.12B | 145.00K | 38.00K |
| Retained Earnings | -2.55B | -2.63B | -2.66B | -2.58B | -2.47B |
| Treasury Stock & Other | -15.96M | -16.17M | -16.25M | -16.67M | -26.58M |
| Total Common Equity | 577.31M | 478.36M | 452.90M | -2.60B | -2.50B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | 2.25B | 2.22B |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | 2.25B | 2.22B |
|
|
|||||
| Total Common Equity | 577.31M | 478.36M | 452.90M | -2.60B | -2.50B |
| Total Preferred Equity | -- | -- | -- | 2.25B | 2.22B |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 577.31M | 478.36M | 452.90M | -353.75M | -277.19M |
|
|
|||||